Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB

NCT03828201 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

271

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis, Multidrug-Resistant

Interventions

DRUG: Delamanid
DRUG: Levofloxacin
DRUG: Bedaquiline
DRUG: Clofazimine
DRUG: Linezolid

Sponsor

Boston University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]